L851-1501 Screening compound: 3-[3-(3-benzyl-1,2,4-oxadiazol-5-yl)-1-methyl-1H,4H,5H,6H,7H-pyrazolo[4,3-c]pyridine-5-carbonyl]-2-chloropyridine

L851-1501 Screening compound: 3-[3-(3-benzyl-1,2,4-oxadiazol-5-yl)-1-methyl-1H,4H,5H,6H,7H-pyrazolo[4,3-c]pyridine-5-carbonyl]-2-chloropyridine
L851-1501 Screening compound: 3-[3-(3-benzyl-1,2,4-oxadiazol-5-yl)-1-methyl-1H,4H,5H,6H,7H-pyrazolo[4,3-c]pyridine-5-carbonyl]-2-chloropyridine alternative view

Chemical Structure Depiction of ChemDiv screening compound L851-1501
3-[3-(3-benzyl-1,2,4-oxadiazol-5-yl)-1-methyl-1H,4H,5H,6H,7H-pyrazolo[4,3-c]pyridine-5-carbonyl]-2-chloropyridine

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

L851-1501

Molecular Formula

C22H19ClN6O2 (C22 H19 ClN6 O2)

Compound Name

3-[3-(3-benzyl-1,2,4-oxadiazol-5-yl)-1-methyl-1H,4H,5H,6H,7H-pyrazolo[4,3-c]pyridine-5-carbonyl]-2-chloropyridine

IUPAC name

3-[3-(3-benzyl-124-oxadiazol-5-yl)-1-methyl-1H4H5H6H7H-pyrazolo[43-c]pyridine-5-carbonyl]-2-chloropyridine

SMILES

Cn(c(CC1)c2CN1C(c1cccnc1Cl)=O)nc2-c1nc(Cc2ccccc2)no1

InChI

InChI=1S/C22H19ClN6O2/c1-28-17-9-11-29(22(30)15-8-5-10-24-20(15)23)13-16(17)19(26-28)21-25-18(27-31-21)12-14-6-3-2-4-7-14/h2-8,10H,9,11-13H2,1H3

InChI Key

ARXNGSHUIBWEKY-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27642003

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

434.88

Hydrogen Bond Acceptors Count

7.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

5.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

2.235

Distribution Coefficient, logD

2.235

Water Solubility, LogSw

-3.16

Polar Surface Area

73.648

Acid Dissociation Constant (pKa)

20.50

Base Dissociation Constant (pKb)

-0.52

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

22.70

L851-1501 in Drug Discovery

Included in Screening Libraries

Cysteine Proteases Inhibitors Library (7839 compounds)

Hsp90-Targeted Library (11355 compounds)

?ysteine Targeted Covalent Library (39471 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Infections
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Nervous system
  • Cardiovascular
  • Skin
  • Metabolic
  • Endocrine
  • Immune system
  • Cancer
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic
  • Immune system
Targets:
  • Proteases

References: we are preparing a list of scientific research reports with L851-1501 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound L851-1501?
Check Price and Availability of L851-1501, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of L851-1501 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for L851-1501
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for L851-1501
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of L851-1501 available by request